1. Home
  2. QNRX vs GITS Comparison

QNRX vs GITS Comparison

Compare QNRX & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNRX
  • GITS
  • Stock Information
  • Founded
  • QNRX 2018
  • GITS 2018
  • Country
  • QNRX United States
  • GITS South Korea
  • Employees
  • QNRX N/A
  • GITS N/A
  • Industry
  • QNRX Medical/Dental Instruments
  • GITS
  • Sector
  • QNRX Health Care
  • GITS
  • Exchange
  • QNRX Nasdaq
  • GITS Nasdaq
  • Market Cap
  • QNRX 5.2M
  • GITS 5.7M
  • IPO Year
  • QNRX N/A
  • GITS N/A
  • Fundamental
  • Price
  • QNRX $15.20
  • GITS $1.48
  • Analyst Decision
  • QNRX
  • GITS
  • Analyst Count
  • QNRX 0
  • GITS 0
  • Target Price
  • QNRX N/A
  • GITS N/A
  • AVG Volume (30 Days)
  • QNRX 1.0M
  • GITS 54.6K
  • Earning Date
  • QNRX 11-06-2025
  • GITS 11-12-2025
  • Dividend Yield
  • QNRX N/A
  • GITS N/A
  • EPS Growth
  • QNRX N/A
  • GITS N/A
  • EPS
  • QNRX N/A
  • GITS N/A
  • Revenue
  • QNRX N/A
  • GITS $29.00
  • Revenue This Year
  • QNRX N/A
  • GITS N/A
  • Revenue Next Year
  • QNRX N/A
  • GITS N/A
  • P/E Ratio
  • QNRX N/A
  • GITS N/A
  • Revenue Growth
  • QNRX N/A
  • GITS N/A
  • 52 Week Low
  • QNRX $5.01
  • GITS $0.87
  • 52 Week High
  • QNRX $48.30
  • GITS $9.78
  • Technical
  • Relative Strength Index (RSI)
  • QNRX 62.47
  • GITS 32.68
  • Support Level
  • QNRX $8.05
  • GITS $1.43
  • Resistance Level
  • QNRX $14.03
  • GITS $1.68
  • Average True Range (ATR)
  • QNRX 1.82
  • GITS 0.11
  • MACD
  • QNRX 0.22
  • GITS -0.01
  • Stochastic Oscillator
  • QNRX 94.43
  • GITS 16.67

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About GITS Global Interactive Technologies Inc. Common Stock

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

Share on Social Networks: